Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
PFM Health Sciences, LP - 31 Mar 2025 SCHEDULE 13G/A Report for PMV Pharmaceuticals, Inc. Common stock, par $0.00001 per share (the "Shares") (PMVP)
- Filing manager
- PFM Health Sciences, LP
- Reporting owner
- PFM Health Sciences, LP
- Beneficially owned shares
- 3,301,942 shares
- Large-stake signal
-
Ownership
6.4%Beneficial ownership of this reported class.
Shares
3,301,942 sharesShares beneficially owned as disclosed.
Event date
31 Mar 2025Date tied to the ownership event or amendment.
Accepted by SEC
15 May 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 6.4%
- Symbol
- PMVP
- Shares outstanding
- 51,592,844 shares
- SEC form
- SCHEDULE 13G/A
- Accepted by SEC
- 15 May 2025, 16:08:18 UTC
- Event date
- 31 Mar 2025
- Prior SEC filing
- 21 Feb 2025
- Next SEC filing
- 14 Aug 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
6 source fields
Key filing fact
PFM Health Sciences, LP disclosed 6.4% ownership in PMV Pharmaceuticals, Inc. Common stock, par $0.00001 per share (the "Shares") (PMVP) on 31 Mar 2025.
Key facts
- PFM Health Sciences, LP filed SCHEDULE 13G/A for PMV Pharmaceuticals, Inc. Common stock, par $0.00001 per share (the "Shares") (PMVP).
- Disclosed ownership: 6.4%.
- Date of event: 31 Mar 2025.
Change
- Previous schedule filing date: 21 Feb 2025.
- Current filing was accepted on 15 May 2025, 16:08.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| PFM Health Sciences, LP | 6.4% | 3,301,942 | 0 | 3,301,942 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| PFM Health Sciences GP, LLC | 6.4% | 3,301,942 | 0 | 3,301,942 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| Partner Asset Management, LLC | 6.4% | 3,301,942 | 0 | 3,301,942 | /s/ Darren Mooney | Darren Mooney, Authorized Signatory | |
| Brian D. Grossman | 6.4% | 3,301,942 | 0 | 3,301,942 | /s/ Darren Mooney | Darren Mooney, attorney-in-fact* |
CIK / CUSIP context first